Zoetis Declares First Quarter 2024 Dividend; Board Approves 15% Payment Increase
07 Dicembre 2023 - 10:05PM
Business Wire
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a
dividend of $0.432 per share for the first quarter of 2024, an
increase of 15% from the quarterly dividend rate paid in 2023. The
dividend will be paid on Friday, March 1, 2024, to all holders of
record of the Company’s common stock as of the close of business on
Friday, January 19, 2024.
“Zoetis has continued to perform well this year thanks to our
diverse and innovative product portfolio,” said Wetteny Joseph,
Executive Vice President and Chief Financial Officer at Zoetis. “I
am pleased to announce that we are increasing our dividend in 2024
as part of our commitment to returning excess capital to
shareholders.”
About Zoetis
As the world’s leading animal health company, Zoetis is driven
by a singular purpose: to nurture our world and humankind by
advancing care for animals. After innovating ways to predict,
prevent, detect, and treat animal illness for more than 70 years,
Zoetis continues to stand by those raising and caring for animals
worldwide -- from veterinarians and pet owners to livestock farmers
and ranchers. The company’s leading portfolio and pipeline of
medicines, vaccines, diagnostics and technologies make a difference
in over 100 countries. A Fortune 500 company, Zoetis generated
revenue of $8.1 billion in 2022 with approximately 13,800
employees. For more information, visit www.zoetis.com.
DISCLOSURE NOTICES
Forward-Looking Statements: This
press release contains forward-looking statements, which reflect
the current views of Zoetis with respect to business plans or
prospects, future operating or financial performance, future use of
cash and dividend payments, and other future events. These
statements are not guarantees of future performance or actions.
Forward-looking statements are subject to risks and uncertainties.
If one or more of these risks or uncertainties materialize, or if
management's underlying assumptions prove to be incorrect, actual
results may differ materially from those contemplated by a
forward-looking statement. Forward-looking statements speak only as
of the date on which they are made. Zoetis expressly disclaims any
obligation to update or revise any forward-looking statement,
whether as a result of new information, future events or otherwise.
A further list and description of risks, uncertainties and other
matters can be found in our most recent Annual Report on Form 10-K,
including in the sections thereof captioned “Forward-Looking
Statements and Factors That May Affect Future Results” and “Item
1A. Risk Factors,” in our Quarterly Reports on Form 10-Q and in our
Current Reports on Form 8-K. These filings and subsequent filings
are available online at www.sec.gov, www.zoetis.com, or on request
from Zoetis.
ZTS-COR ZTS-IR ZTS-FIN
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231207913574/en/
Media: Bill Price 1-973-443-2742
(o) william.price@zoetis.com Laura Panza 1-973-975-5176 (o)
laura.panza@zoetis.com Investors:
Steve Frank 1-973-822-7141 (o) steve.frank@zoetis.com Nick
Soonthornchai 1-973-443-2792 (o) nick.soonthornchai@zoetis.com
Grafico Azioni Zoetis (NYSE:ZTS)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Zoetis (NYSE:ZTS)
Storico
Da Giu 2023 a Giu 2024